tiprankstipranks

Giant Biogene Clarifies Impact of Regulatory Measures on Chairman

Story Highlights
Giant Biogene Clarifies Impact of Regulatory Measures on Chairman

An announcement from Giant Biogene Holding Co. Ltd. ( (HK:2367) ) is now available.

Giant Biogene Holding Co., Ltd. announced that Xi’an Triangle Defense Co., Ltd., where its Chairman Mr. Yan Jianya also serves as Chairman, received regulatory warnings from the Shaanxi Securities Regulatory Bureau due to breaches in internal control and information disclosure. The company clarified that these regulatory measures do not relate to its operations and will not materially impact its business, affirming Mr. Yan Jianya’s suitability to continue his role.

More about Giant Biogene Holding Co. Ltd.

YTD Price Performance: 40.98%

Average Trading Volume: 3,236,937

Technical Sentiment Consensus Rating: Sell

Current Market Cap: HK$72.25B

For an in-depth examination of 2367 stock, go to TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App